MRVI

MRVI Operating Cash Flow (Statement)

-$25.26MTTM · USD

Period ending:

MRVI FY Cash from OperationsUSD
MRVI FY Cash from Operations2018-12-31: -$186.00K2019-12-31: $24.12M2020-12-31: $152.19M2021-12-31: $368.57M2022-12-31: $535.98M2023-12-31: $126.22M2024-12-31: $7.47M2025-12-31: -$57.57M$535.98M-$57.57M
2018-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

MRVI operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 8 observations from Dec 31, 2018 to Dec 31, 2025.

Maravai Lifesciences Holdings Inc Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
-57,573,000
7,465,000
126,224,000
535,977,000
368,570,000
152,187,000
24,115,000
-186,000

Compare operating cash flow (statement)

All MRVI financial metrics · MRVI stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.